𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of human breast cancer cell growth by N-(4-hydroxyphenyl) retinamide and 13-cis-retinoic acid alone and in combination with tamoxifen

✍ Scribed by Lama, G; Angelucci, C; Recchia, F; Sica, G

Book ID
122973228
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
156 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of cancer cell growth by all-
Inhibition of cancer cell growth by all- trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression
✍ Guizhong Liu; Min Wu; Giovanni Levi; Nicoletta Ferrari πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 189 KB πŸ‘ 2 views

In order to better understand the mechanisms that underlie the antiproliferative effect of retinoids, we have examined the response of human carcinoma cell lines to all-trans retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4HPR) in terms of cell growth, apoptosis and regulation of retinoic ac

Is growth inhibition and induction of ap
Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
✍ Carsten-Henning Ohlmann; Christine Jung; Gabriele Jaques πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 303 KB πŸ‘ 1 views

## Abstract The synthetic retinoid fenretinide [N‐(4‐hydroxyphenyl)retinamide, 4‐HPR] has demonstrated growth inhibition and induction of apoptosis of various malignant cells, including lung cancer cell lines. 4‐HPR is now being investigated in several clinical trials. In our study, we show that 4‐